Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Requirements for Negative Pre- Departure COVID-19 Test Result or Documentation of Recovery from COVID- 19 for all Airline or Other Aircraft Passengers Traveling to the United States from the People's Republic of China (PRC). This data collection is created to protect the U.S. population from potential importation, transmission, and spread of new COVID-19 variants into the United States from the PRC.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 11 (Wednesday, January 18, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 11 (Wednesday, January 18, 2023)]
[Notices]
[Pages 2927-2928]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-00810]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-23-1380; Docket No. CDC-2023-0006]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Requirements for Negative Pre-
Departure COVID-19 Test Result or Documentation of Recovery from COVID-
19 for all Airline or Other Aircraft Passengers Traveling to the United
States from the People's Republic of China (PRC). This data collection
is created to protect the U.S. population from potential importation,
transmission, and spread of new COVID-19 variants into the United
States from the PRC.
DATES: CDC must receive written comments on or before March 20, 2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0006 by any of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffery M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffery M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: <a href="/cdn-cgi/l/email-protection#7b1416193b181f18551c140d"><span class="__cf_email__" data-cfemail="d4bbb9b694b7b0b7fab3bba2">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Requirements for Negative Pre-Departure COVID-19 Test Result or
Documentation of Recovery from COVID-19 for all Airline or Other
Aircraft Passengers Traveling to the United States from the People's
Republic of China (OMB Control No. 0920-1380, Exp. 6/30/2023)--New--
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
COVID-19 is surging in the People's Republic of China (PRC) because
of
[[Page 2928]]
recent decisions to remove mitigation measures. The population in the
PRC has not had extensive exposure to the virus that causes COVID-19
and, therefore, has not developed immune protection through prior
infection. The recent surge in COVID-19 transmission, particularly in a
large population such as the PRC, increases the potential for new
variants to emerge that could be introduced to the United States.
Considering the potential danger to public health posed by emerging
new variants in the PRC, CDC has determined that proactive,
preventative measures must be implemented now to protect the U.S.
population from potential importation, transmission, and spread of new
COVID-19 variants into the United States.
Pursuant to 42 CFR 71.20 and 71.31(b) and as set forth in greater
detail below, this Notice and associated CDC Order will prohibit the
boarding of any passenger two years of age or older on an itinerary
that includes the United States, on:
<bullet> any aircraft departing from the PRC, or
<bullet> any aircraft departing from a Designated Airport if the
passenger within the ten (10) days prior to their departure for the
United States has been in the PRC, unless the passenger presents paper
or digital documentation of one of the following requirements or meets
a limited exception:
1. A negative pre-departure viral test result for SARS-CoV-2
conducted on a specimen collected no more than two (2) calendar days
before the flight's departure from the PRC (Qualifying Test)
OR
2. Documentation of having recovered from COVID-19 in the past 90
days in the form of one of the following (i.e., Documentation of
Recovery):
a. A positive viral test result for SARS-CoV-2 conducted on a
specimen collected more than 10 calendar days but fewer than 91
calendar days before the flight's departure; OR
b. A positive viral test result for SARS-CoV-2 conducted on a
specimen collected 10 or fewer calendar days before the flight's
departure AND a signed letter from a licensed healthcare provider or
public health official stating that the passenger's COVID-19 symptoms
began more than 10 calendar days before the flight's departure.
CDC may grant a humanitarian exception in very limited
circumstances only when an individual must travel to the United States
to preserve health (e.g., emergency medical evacuations, life-saving
medical treatment) or safety (e.g., violence) and pre-departure testing
cannot be accessed or completed before travel because of exigent
circumstances. Air passengers will also be required to provide an
attestation, attesting that the information they present is true.
CDC requests OMB approval for an estimated 5,208,373 annual burden
hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Air Passenger................. Attestation--Pro 2,500,000 1 2 5,000,000
of of Negative
COVID-19 Test
Result or
Documentation
of Recovery for
Air Passengers
from the
People's
Republic of
China.
Airline Desk Agent............ Attestation--Pro 2,500,000 1 8/60 208,333
of of Negative
COVID-19 Test
Result or
Documentation
of Recovery for
Air Passengers
from the
People's
Republic of
China.
Air Passenger................. Request 20 1 2 40
Humanitarian
Exception--(No
form).
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 5,208,373
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-00810 Filed 1-17-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.